Position
Essential Partners LLC in Compass Therapeutics, Inc.
Back to the book · All holders of CMPX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $0$5.33 → $5.33
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q3 2025 | 19 | $67 | — | — | — | 0.0% |
| Q4 2025 | 9 | $48 | $5.33 | $16 | −$35 | 0.0% |
| Q1 2026 | 9 | $48 | $5.33 | $0 | $0 | 0.0% |